SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PFE (Pfizer) How high will it go?
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
9523 158 0 PFE
Emcee:  Lynn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8898Court of appeals rules in favour of US-based company Pfizer suit brings RanbaxyQualified Opinion-11/24/2005
8897Pfizer licenses inflammation portfolio from Incyte Pfizer is to pay up to $803 mQualified Opinion-11/23/2005
8896New study suggests efficacy of statins in cognitive decline A new study has founQualified Opinion-11/23/2005
8895Pfizer selects compound for development in eye disease Pfizer has selected a devQualified Opinion-11/23/2005
8894Apparently, the intent of part of the study was to measure this impact and patieRobohogs-11/18/2005
8893Regarding my favorite subject U.S. brokerage analysts <g> Usually at leasQualified Opinion-11/18/2005
8892Pfizer To Cut 490 Workers When NJ Plant Closes -Report Friday November 18, Qualified Opinion-11/18/2005
8891Excerpt: In what may be the most surprising finding of the meeting, a study caQualified Opinion-11/18/2005
8890New Data: Pfizer's Varenicline is an Effective and Safe Treatment for SmokinQualified Opinion-11/15/2005
8889Excerpt: There was an 11 percent reduction in major coronary events in Lipitor pQualified Opinion-11/15/2005
8888Pfizer Share Sell-Off Seen As 'Overdone' Peter Kang, 11.15.05, 3:29 PM Qualified Opinion-11/15/2005
8887Pfizer's Torcetrapib/Atorvastatin Significantly Raised 'Good' CholesQualified Opinion-11/15/2005
8886Has Lipitor Reached Its Limit? Link: forbes.comQualified Opinion-11/15/2005
8885Abbott Laboratories Shares Drop to New 52-Week Low After Study Fails to Lower HeQualified Opinion-11/14/2005
8884>Those are two completely different markets.< I'm looking for growth Qualified Opinion-11/13/2005
8883<b> More on PFE’s Norvasc and the importance of “central” blood pressure: DewDiligence_on_SI-11/13/2005
8882<i>Good clinical data on Norvasc should help in the U.S. until sometime inDewDiligence_on_SI-11/13/2005
8881Good clinical data on Norvasc should help in the U.S. until sometime in 2007. HoQualified Opinion-11/13/2005
8880I’d really like to know why the Caduet MAA was unacceptable to the EMEA. Good clDewDiligence_on_SI-11/13/2005
8879New Data Show Hypertensive Patients Taking Norvasc-Based Regimen Achieved BetterQualified Opinion-11/13/2005
8878Biogen Idec CEO says not interested in Serono Sat Nov 12, 2005 05:14 AM ET ZURQualified Opinion-11/12/2005
8877<i>Caduet had international sales of $5 million for the first 9 months of DewDiligence_on_SI-11/10/2005
8876Pfizer working on anti-smoking drug Pfizer, big player in heart-disease drugs, gQualified Opinion-11/10/2005
8875Caduet had international sales of $5 million for the first 9 months of 2005 per Qualified Opinion-11/10/2005
8874U.S. Requests Information On Pfizer's Payment to Doctors By SCOTT HENSLEY Doc Bones-11/10/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News